Skip to main content
MedicHelpLine
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINJECTIONStandard

PAMIDRONATE DISODIUM

PAMIDRONATE DISODIUM

Standard Dose
60MG/VIAL
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Prescription
Summary

Approval overview PAMIDRONATE DISODIUM is listed in Drugs@FDA under application 077433 (ANDA).

Marketing status: Prescription Active ingredient PAMIDRONATE DISODIUM Form and strength INJECTABLE;INJECTION - 60MG/VIAL Sponsor AREVA PHARMS Submission history Latest submission status date: 2016-11-29 00:00:00.

Structured Monograph

Clinical summary

Approval overview PAMIDRONATE DISODIUM is listed in Drugs@FDA under application 077433 (ANDA). Marketing status: Prescription Active ingredient PAMIDRONATE DISODIUM Form and strength INJECTABLE;INJECTION - 60MG/VIAL Sponsor AREVA PHARMS Submission history Latest submission status date: 2016-11-29 00:00:00. Submission type: SUPPL.

Monitoring

  • Review priority: STANDARD
  • Marketing status: Prescription

Interaction Notes

  • No interaction notes stored yet.